Document is current
Any future updates will be listed below
-
Authors
Park, Gabee
Hwang, Dae Yeon
Kim, Do Young
Han, Ji Young
Lee, Euiseon
Hwang, Hwakyung
Park, Jeong Seop
Kim, Dae Wook
Hong, Seonmin
Yim, Sung Vin
Hong, Hyun Sook
Son, Youngsook
-
Funding
Funding for this research was provided by:
Ministry of Health and Welfare (HI18C1492)
Ministry of Science and ICT, South Korea (23C0110L1)
Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California Los Angeles
- License Information
-
More Information
Article History
Received: 9 July 2024
Accepted: 10 October 2024
First Online: 31 October 2024
Declarations
:
: (1) Animal experiment for the efficacy of dual stem cell in limb ischemia (2) The Ethics Committee for Experimental Animals of Kyung Hee University Hospital (3) KHMC-IACUC 20-008 (4) 2021.3.11. The protocols for animal experiments adhere to the ARRIVE (Animal Research: Reporting of in Vivo Experiments) guidelines. (1) Fresh BM of human was obtained from donors for effectiveness of stem cell therapy (2) The Institutional Review Board of Kyung Hee University hospital (3) 2020-09-036 (4) 2020.10.23 Patient provided written informed consent for the use of samples. Human BM-MNCs, frozen manufactured by Lonza were isolated from donated human tissue after obtaining permission for their use in research applications by informed consent or legal authorization. Human BM-MNCs frozen manufactured by STEMCELL Technologies were obtained using Institutional Review Board (IRB) approved consent forms and protocols.
: All authors confirm their consent for publication.
: All authors declare that they have no conflicts of interes.t
